Last deal

Amount

Venture - Series Unknown

Stage

07.12.2023

Date

5

all rounds

$3.4M

Total amount

General

About Company
Functional Fluidics standardizes clinical blood function assays to assess individual patient response.

Industry

Sector :

Subsector :

founded date

01.05.2014

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The Detroit-based company, founded in 2014, offers a blood diagnostics unit to diagnose sickle cell disease and bleeding and clotting disorders. Their testing platform assesses the health of red blood cells using two proprietary tests: the mechanical fragility test and the adhesion test. Functional Fluidics also provides Covid-19 and Covid-19 Antibody Tests for workplaces, schools, and colleges.
Contacts